Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03175042 · ClinicalTrials.gov registry record
Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic
A clinical trial of Anemia in Pregnancy, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT03175042: Completed study of Anemia in Pregnancy, sponsored by The University of Texas Medical Branch, Galveston.
NCT03175042 is a study of Anemia in Pregnancy that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03175042, a study of Anemia in Pregnancy, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Pregnant patients in the UT Medical Branch outpatient obstetric clinic are screened for anemia via blood draw at first prenatal visit. Those who meet Center for Disease Control (CDC) criteria for anemia during pregnancy (hemoglobin less than 11g/dL in first and third trimesters and hemoglobin less than 10.5g/dL during the second trimester), will be approached for participation in this study. It is the protocol of the UT Medical Branch outpatient obstetric clinic to repeat a blood draw every 4 weeks in patients with anemia. At the time of their blood draw, patients who participate in our study will have the Masimo Spot Non-invasive Hemoglobin monitor placed on our finger. The primary aim of the study is to see how accurate the non-invasive monitor is compared with blood draw. With the potential benefit being earlier diagnosis of anemia and easier method to ensure improvement in the hemoglobin.
Primary Outcome
Comparing hemoglobin values between CBC and non-invasive monitor
Conditions Studied
Interventions
- DEVICE Masimo spot hemoglobin non-invasive monitor
Study Locations (1)
Texas
- University of Texas Medical Branch - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2017-12-31 |
What the finished NCT03175042 record still lists
NCT03175042 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Anemia in Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Masimo spot hemoglobin non-invasive monitor is the first listed.
NCT03175042 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03175042 about?
NCT03175042 is a clinical study titled "Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic". Pregnant patients in the UT Medical Branch outpatient obstetric clinic are screened for anemia via blood draw at first prenatal visit. Those who meet Center for Disease Control (CDC) criteria for anemia during pregnancy (hemoglobin less than 11g/dL in first and third trimesters and hemoglobin less t...
What is the current status of trial NCT03175042?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2017-06-13. Estimated completion is 2017-12-31.
What conditions does trial NCT03175042 study?
This clinical trial studies the following conditions: Anemia in Pregnancy.
What interventions are being tested in trial NCT03175042?
The interventions under investigation include: Masimo spot hemoglobin non-invasive monitor (DEVICE).
Who is sponsoring clinical trial NCT03175042?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03175042 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI